← Eichor
Condition: Hepatotoxicity Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatotoxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pharmacogenomics of Asparaginase Induced Hepatotoxicity
Phase N/A · 2 location(s) · University of Southern California · NCT03568266A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
Phase N/A · 8 location(s) · Daiichi Sankyo · NCT04635111Checkpoint Inhibitor-induced Liver Injury
Phase N/A · 1 location(s) · University of Nottingham · NCT04476563Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
EARLY_Phase 1 · 2 location(s) · Children's Hospital of Orange County · NCT05501899Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT06649474
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.